See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

Presenter: James Hermiller Jr

October 23, 2012

Presentation TCT 2012

ELM Presentation

Presenter: J. Dawn Abbott

October 23, 2012

Presentation TCT 2012

Vascular Access Choice and Radiation Exposure

Presenter: Sanjit Jolly

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(2)

Presenter: Dierk Scheinert

October 23, 2012

Presentation TCT 2012

Introduction(5)

Presenter: David Morrow

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(4)

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

Preclinical Review: Experimental Pathways for Evaluation of Drug Transfer, Tissue Pharmacokinetics, and Vascular Effects

Presenter: Elazer Edelman

October 23, 2012

Presentation TCT 2012

CABG Plus PCI for MVD: The Hybrid Option

Presenter: David Zhao

October 23, 2012

Presentation TCT 2012

Case 2: During an EVAR or TEVAR

Presenter: James McKinsey

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(5)

Presenter: Paul Sobotka

October 23, 2012

Advertisement

Slides

TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

ELM Presentation

Vascular Access Choice and Radiation Exposure

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(2)

Introduction(5)

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(4)

Preclinical Review: Experimental Pathways for Evaluation of Drug Transfer, Tissue Pharmacokinetics, and Vascular Effects

CABG Plus PCI for MVD: The Hybrid Option

Case 2: During an EVAR or TEVAR

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(5)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content